scabronine-g and Dementia

scabronine-g has been researched along with Dementia* in 1 studies

Reviews

1 review(s) available for scabronine-g and Dementia

Article	Year
[Development of anti-dementia drugs related to neurotrophic factors]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2006, Volume: 126, Issue:9 Neurotrophic factor-like substances and inducers of neurotrophic factor biosynthesis have enormous therapeutic potential for serious neuronal diseases such as Alzheimer's disease. Here, we discuss about the pharmacological effects of scabronines and beta-eudesmol as promising candidates of leading compounds against the dementia. In addition, we discuss about the signaling pathway of nerve growth factor and cyclic AMP in order to seek the signaling molecules as targets of drug development. Topics: Cyclic AMP; Dementia; Diterpenes; Drug Design; Extracellular Signal-Regulated MAP Kinases; Nerve Growth Factors; Nootropic Agents; Sesquiterpenes, Eudesmane; Signal Transduction	2006

Article

Year

[Development of anti-dementia drugs related to neurotrophic factors].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2006, Volume: 126, Issue:9

Neurotrophic factor-like substances and inducers of neurotrophic factor biosynthesis have enormous therapeutic potential for serious neuronal diseases such as Alzheimer's disease. Here, we discuss about the pharmacological effects of scabronines and beta-eudesmol as promising candidates of leading compounds against the dementia. In addition, we discuss about the signaling pathway of nerve growth factor and cyclic AMP in order to seek the signaling molecules as targets of drug development.

Topics: Cyclic AMP; Dementia; Diterpenes; Drug Design; Extracellular Signal-Regulated MAP Kinases; Nerve Growth Factors; Nootropic Agents; Sesquiterpenes, Eudesmane; Signal Transduction

2006